Marie-emilie E. Dourthe
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.
Journal: Leukemia
Published: April 03, 2026
Association of immune relevant single nucleotide polymorphisms with ALK-positive anaplastic large cell lymphoma presentation and outcome: results of the immuno ALCL study.
Journal: Journal of translational medicine
Published: September 18, 2025
Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adults.
Journal: HemaSphere
Published: September 12, 2025
Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real-world study.
Journal: British journal of haematology
Published: September 12, 2025
Homeodomain-driven oncogenic diversion to a γδTCR phenotype in T-cell acute lymphoblastic leukemia.
Journal: Blood
Published: July 02, 2025
Homeodomain-driven oncogenic diversion to a TCRγδ phenotype in T-cell Acute Lymphoblastic Leukemia.
Journal: Blood
Published: July 02, 2025
Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemia.
Journal: Leukemia
Published: June 04, 2025
Choice of bridging therapy prior to reinjection of autologous CAR-T cells in patients aged 0-25 years treated for B-ALL (SFGM-TC)
Journal: Bulletin du cancer
Published: May 22, 2025
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 25, 2024
Last Updated: 09/26/2026